Locoregional Stomach Cancer
Gastric Adenocarcinoma
Male, 35 years
Patient Internal ID: 302683160
ICD-10 code
C16.2 Malignant Neoplasm of Body of Stomach
Diagnosis (Incl. Metastases/Stage) and Year
June 2020
Adenocarcinoma of Gastric Body cT3N1Mo G3 (ypT3N3a LV1 R0).
Previous Treatment
Chemotherapy (FLOT4), Surgery (Gastrectomy) + HIPEC, Chemotherapy (Cisplatin + Fluorouracil).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of ~40 months from diagnosis.
Treatment Provided
Autologous DCV (7 doses) and CIK (9 doses) over a period of 6 months.
Patient Survival/Condition and Year
Date of Review: 15/10/2023
Patient survived 21 months from diagnosis, he had reached a stable disease control, however, he died due to other medical complications. It can be concluded that Immunotherapy, alongside Chemotherapy, Surgery and HIPEC Chemotherapy, benefited for disease control.
